EA202090853A1 - Новые соли - Google Patents
Новые солиInfo
- Publication number
- EA202090853A1 EA202090853A1 EA202090853A EA202090853A EA202090853A1 EA 202090853 A1 EA202090853 A1 EA 202090853A1 EA 202090853 A EA202090853 A EA 202090853A EA 202090853 A EA202090853 A EA 202090853A EA 202090853 A1 EA202090853 A1 EA 202090853A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- salts
- new salts
- methyl
- new
- diazaspiro
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 3
- GCZUIPVRHLYYOG-UHFFFAOYSA-N 7-methyl-2-[4-methyl-6-[4-(trifluoromethyl)phenyl]pyrimidin-2-yl]-1,7-diazaspiro[4.4]nonan-6-one Chemical class O=C1N(C)CCC11NC(C=2N=C(C=C(C)N=2)C=2C=CC(=CC=2)C(F)(F)F)CC1 GCZUIPVRHLYYOG-UHFFFAOYSA-N 0.000 abstract 1
- 102000016913 Voltage-Gated Sodium Channels Human genes 0.000 abstract 1
- 108010053752 Voltage-Gated Sodium Channels Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762564744P | 2017-09-28 | 2017-09-28 | |
| PCT/US2018/053520 WO2019067961A1 (en) | 2017-09-28 | 2018-09-28 | NEW SALTS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202090853A1 true EA202090853A1 (ru) | 2020-08-27 |
Family
ID=65902742
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202090853A EA202090853A1 (ru) | 2017-09-28 | 2018-09-28 | Новые соли |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20200255438A1 (enExample) |
| EP (1) | EP3687533A4 (enExample) |
| JP (1) | JP2020536070A (enExample) |
| KR (1) | KR20200060404A (enExample) |
| CN (1) | CN111343978A (enExample) |
| AU (2) | AU2018338884A1 (enExample) |
| BR (1) | BR112020005992A2 (enExample) |
| CA (1) | CA3074923A1 (enExample) |
| EA (1) | EA202090853A1 (enExample) |
| IL (1) | IL273520A (enExample) |
| MA (1) | MA50669A (enExample) |
| MX (1) | MX2020003741A (enExample) |
| SG (1) | SG11202002200UA (enExample) |
| WO (1) | WO2019067961A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3077088A1 (en) | 2017-10-10 | 2019-04-18 | Biogen Inc. | Process for preparing spiro derivatives |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2789711C (en) * | 2010-02-17 | 2014-08-05 | Amgen Inc. | Aryl carboxamide derivatives as sodium channel inhibitors for treatment of pain |
| EA201491990A1 (ru) * | 2012-05-03 | 2015-02-27 | Новартис Аг | L-малатная соль 2,7-диазаспиро[4.5]дец-7-иловых производных и их кристаллические формы в качестве агонистов грелиновых рецепторов |
| GB201209015D0 (en) * | 2012-05-22 | 2012-07-04 | Convergence Pharmaceuticals | Novel compounds |
-
2018
- 2018-09-28 MX MX2020003741A patent/MX2020003741A/es unknown
- 2018-09-28 EP EP18861356.6A patent/EP3687533A4/en not_active Withdrawn
- 2018-09-28 MA MA050669A patent/MA50669A/fr unknown
- 2018-09-28 EA EA202090853A patent/EA202090853A1/ru unknown
- 2018-09-28 WO PCT/US2018/053520 patent/WO2019067961A1/en not_active Ceased
- 2018-09-28 US US16/651,577 patent/US20200255438A1/en not_active Abandoned
- 2018-09-28 JP JP2020518078A patent/JP2020536070A/ja not_active Withdrawn
- 2018-09-28 SG SG11202002200UA patent/SG11202002200UA/en unknown
- 2018-09-28 CA CA3074923A patent/CA3074923A1/en not_active Withdrawn
- 2018-09-28 BR BR112020005992-7A patent/BR112020005992A2/pt not_active Application Discontinuation
- 2018-09-28 AU AU2018338884A patent/AU2018338884A1/en not_active Abandoned
- 2018-09-28 CN CN201880063113.2A patent/CN111343978A/zh not_active Withdrawn
- 2018-09-28 KR KR1020207009445A patent/KR20200060404A/ko not_active Withdrawn
-
2020
- 2020-03-23 IL IL273520A patent/IL273520A/en unknown
-
2023
- 2023-04-13 AU AU2023202293A patent/AU2023202293A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| AU2023202293A1 (en) | 2023-05-11 |
| EP3687533A4 (en) | 2021-01-20 |
| JP2020536070A (ja) | 2020-12-10 |
| MA50669A (fr) | 2020-08-05 |
| AU2018338884A1 (en) | 2020-04-16 |
| IL273520A (en) | 2020-05-31 |
| KR20200060404A (ko) | 2020-05-29 |
| SG11202002200UA (en) | 2020-04-29 |
| MX2020003741A (es) | 2021-01-08 |
| CA3074923A1 (en) | 2019-04-04 |
| BR112020005992A2 (pt) | 2020-09-29 |
| US20200255438A1 (en) | 2020-08-13 |
| CN111343978A (zh) | 2020-06-26 |
| WO2019067961A1 (en) | 2019-04-04 |
| EP3687533A1 (en) | 2020-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20170695A1 (es) | Compuestos de indol carboxamida utiles como inhibidores de cinasas | |
| EA201591908A1 (ru) | Конденсированные гетероциклические соединения в качестве ингибиторов протеинкиназы | |
| EA201791007A3 (ru) | Соединения и их применения для модуляции гемоглобина | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| EA201591426A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
| EA201790951A1 (ru) | Производные гидроксиалкилзамещенного фенилтриазола и их применение | |
| EA201591432A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
| EA201591427A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
| EA201690502A1 (ru) | Замещенные пиримидиновые ингибиторы bmi-1 | |
| EA201891268A1 (ru) | Соединения, которые можно применять в качестве ингибиторов киназы | |
| EA201992270A3 (ru) | 4-имидазопиридазин-1-ил-бензамиды и 4-имидазотриазин-1-ил-бензамиды в качестве btk-ингибиторов | |
| MX388533B (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso. | |
| EA201590992A1 (ru) | ЗАМЕЩЕННЫЕ ПИРИМИДИНОВЫЕ ОБРАТНЫЕ ИНГИБИТОРЫ Bmi-1 | |
| EA201792348A1 (ru) | Биарильные соединения, применяемые при лечении заболеваний человека в онкологии, нефрологии и иммунологии | |
| EA201992707A1 (ru) | Соединения и их применения для модуляции гемоглобина | |
| EA201590881A1 (ru) | Терапевтические соединения и композиции и их использование в качестве модуляторов пк-m2 | |
| EA201692526A1 (ru) | Замещенные [1,2,4]триазольные соединения | |
| EA201692049A1 (ru) | Гетероарилзамещенные гетероциклилсульфоны | |
| EA201892415A1 (ru) | Полиморфная форма n-{6-(2-гидроксипропан-2-ил)-2-[2-(метилсульфонил)этил]-2н-индазол-5-ил}-6-(трифторметил)пиридин-2-карбоксамида | |
| EA201891609A1 (ru) | Производные 3-((гетеро-)арил)алкил-8-амино-2-оксо-1,3-диазаспиро[4.5]декана | |
| EA201691997A1 (ru) | Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы | |
| MX2018007075A (es) | Compuestos policiclicos como inhibidores de tirosina quinasa de bruton. | |
| EA201790207A1 (ru) | Новые замещенные пиримидиновые соединения | |
| EA201790206A1 (ru) | Новые 2,5-замещенные пиримидины в качестве ингибиторов pde4 | |
| EA201692474A1 (ru) | Производные 1-(циклопент-2-ен-1-ил)-3-(2-гидрокси-3-(арилсульфонил)фенил)мочевины в качестве ингибиторов cxcr2 |